MedTrace Logo

The Therapeutic Role of Kinesio Taping in Primary Dysmenorrhea

NCT07145424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-08-28

No results posted yet for this study

Summary

Purpose: Dysmenorrhea is one of the most common causes of disability in women's health worldwide. It affects women's daily activities and negatively affects their social life. It increases healthcare costs and constitutes a significant burden for both women and society. Therefore, interventions to improve dysmenorrhea are needed. The aim of the study is to examine the effect of kinesio taping (KT) intervention on pain, muscle strength, functional disability, physical activity level, and quality of life.

Methods: Participants with primary dysmenorrhea were divided into kinesio taping (KT) and control (C) groups. The KT group underwent consecutive taping for 12 days starting from the premenstrual week. Trunk muscle strength evaluation, visual analogue scale (VAS), the pressure pain threshold, menstrual distress questionnaire (MDQ), SF-36 quality of life scale, Oswestry disability index (ODI), international physical activity questionnaire (IPAQ) were used as outcome measures.

Conditions

  • Primary Dysmenorrhea
  • Pain Management

Interventions

OTHER

kinesio taping group

The original Kinesio Tape (Kinesio Tex Classic Tape) was used for taping by a physiotherapist with 15 years of experience in the field. The tape was cut into an I-shape and applied to the lower abdominal and lumbo-sacral regions where the participants experienced pain, 10 days prior to the anticipated start of menstruation (Figure 2). The tapes were renewed after four days. This procedure was performed three times and the total taping period was completed as 12 days. The tapes were removed on the third day of menstruation and all outcome measurements were performed again for the post intervention measurements

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2022-05-01
Completion
2022-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07145424 on ClinicalTrials.gov